Cargando…

Pseudohypoaldosteronism in a Neonate Presenting as Life-Threatening Hyperkalemia

Context. Pseudohypoaldosteronism type 1 (PHA1) is a life-threatening disease that causes severe hyperkalemia and cardiac arrest if not treated appropriately or if diagnosis is missed. Objective. To report a case of a newborn with vomiting and lethargy, ultimately diagnosed with pseudohypoaldosteroni...

Descripción completa

Detalles Bibliográficos
Autores principales: Attia, Najya A., Marzouk, Yousef I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745294/
https://www.ncbi.nlm.nih.gov/pubmed/26904317
http://dx.doi.org/10.1155/2016/6384697
_version_ 1782414617161498624
author Attia, Najya A.
Marzouk, Yousef I.
author_facet Attia, Najya A.
Marzouk, Yousef I.
author_sort Attia, Najya A.
collection PubMed
description Context. Pseudohypoaldosteronism type 1 (PHA1) is a life-threatening disease that causes severe hyperkalemia and cardiac arrest if not treated appropriately or if diagnosis is missed. Objective. To report a case of a newborn with vomiting and lethargy, ultimately diagnosed with pseudohypoaldosteronism. Patient. This case presented to the ED at an age of 14 days in hypovolemic shock. There was a family history of sudden infant death, her sister who was diagnosed with CAH and passed away at 3 months of age despite regular hormone replacement. Our patient had cardiac arrest in ED, due to hyperkalemia; while receiving fluid boluses, cardiopulmonary resuscitation was initiated. After stabilization, diagnostic workup demonstrated persistently low sodium, acidosis, and high potassium, which required peritoneal dialysis. Based on these findings, the patient was diagnosed with CAH. It turned out later that the patient had PHA1. Two years later, the patient had a new sibling with the same disease diagnosed at birth and started immediately on treatment without any complication. Conclusions and Outcome. This case highlights the significant diagnostic and therapeutic challenges in treating children with PHA1. Adrenal crisis is not always CAH; delayed diagnosis can lead to complication and even death. The presence of high plasma renin activity, aldosterone, and cortisol, along with the presence of hyponatremia and hyperkalemia, established the diagnosis of PHA type 1 and ruled out CAH.
format Online
Article
Text
id pubmed-4745294
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-47452942016-02-22 Pseudohypoaldosteronism in a Neonate Presenting as Life-Threatening Hyperkalemia Attia, Najya A. Marzouk, Yousef I. Case Rep Endocrinol Case Report Context. Pseudohypoaldosteronism type 1 (PHA1) is a life-threatening disease that causes severe hyperkalemia and cardiac arrest if not treated appropriately or if diagnosis is missed. Objective. To report a case of a newborn with vomiting and lethargy, ultimately diagnosed with pseudohypoaldosteronism. Patient. This case presented to the ED at an age of 14 days in hypovolemic shock. There was a family history of sudden infant death, her sister who was diagnosed with CAH and passed away at 3 months of age despite regular hormone replacement. Our patient had cardiac arrest in ED, due to hyperkalemia; while receiving fluid boluses, cardiopulmonary resuscitation was initiated. After stabilization, diagnostic workup demonstrated persistently low sodium, acidosis, and high potassium, which required peritoneal dialysis. Based on these findings, the patient was diagnosed with CAH. It turned out later that the patient had PHA1. Two years later, the patient had a new sibling with the same disease diagnosed at birth and started immediately on treatment without any complication. Conclusions and Outcome. This case highlights the significant diagnostic and therapeutic challenges in treating children with PHA1. Adrenal crisis is not always CAH; delayed diagnosis can lead to complication and even death. The presence of high plasma renin activity, aldosterone, and cortisol, along with the presence of hyponatremia and hyperkalemia, established the diagnosis of PHA type 1 and ruled out CAH. Hindawi Publishing Corporation 2016 2016-01-19 /pmc/articles/PMC4745294/ /pubmed/26904317 http://dx.doi.org/10.1155/2016/6384697 Text en Copyright © 2016 N. A. Attia and Y. I. Marzouk. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Attia, Najya A.
Marzouk, Yousef I.
Pseudohypoaldosteronism in a Neonate Presenting as Life-Threatening Hyperkalemia
title Pseudohypoaldosteronism in a Neonate Presenting as Life-Threatening Hyperkalemia
title_full Pseudohypoaldosteronism in a Neonate Presenting as Life-Threatening Hyperkalemia
title_fullStr Pseudohypoaldosteronism in a Neonate Presenting as Life-Threatening Hyperkalemia
title_full_unstemmed Pseudohypoaldosteronism in a Neonate Presenting as Life-Threatening Hyperkalemia
title_short Pseudohypoaldosteronism in a Neonate Presenting as Life-Threatening Hyperkalemia
title_sort pseudohypoaldosteronism in a neonate presenting as life-threatening hyperkalemia
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745294/
https://www.ncbi.nlm.nih.gov/pubmed/26904317
http://dx.doi.org/10.1155/2016/6384697
work_keys_str_mv AT attianajyaa pseudohypoaldosteronisminaneonatepresentingaslifethreateninghyperkalemia
AT marzoukyousefi pseudohypoaldosteronisminaneonatepresentingaslifethreateninghyperkalemia